CCM

Catalio Capital Management Portfolio holdings

AUM $477M
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$403M
AUM Growth
-$53.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
45
New
Increased
Reduced
Closed

Top Buys

1
+$21.3M
2
+$19.6M
3
+$13.7M
4
BDX icon
Becton Dickinson
BDX
+$12.7M
5
SLNO icon
Soleno Therapeutics
SLNO
+$11.5M

Top Sells

1
+$28.2M
2
+$24.8M
3
+$19.7M
4
EXAS icon
Exact Sciences
EXAS
+$17.4M
5
MASI icon
Masimo
MASI
+$14.4M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDX icon
1
Becton Dickinson
BDX
$54.7B
$46.7M 11.36%
203,965
+55,350
SWTX
2
DELISTED
SpringWorks Therapeutics
SWTX
$33.5M 8.14%
758,533
-6,135
BBIO icon
3
BridgeBio Pharma
BBIO
$10.8B
$33.3M 8.1%
962,883
+64,425
EW icon
4
Edwards Lifesciences
EW
$44.2B
$31.6M 7.68%
435,588
+102,444
ASND icon
5
Ascendis Pharma
ASND
$12.4B
$30.5M 7.41%
195,523
-20,064
CYTK icon
6
Cytokinetics
CYTK
$7.1B
$23.5M 5.73%
585,812
+128,225
VCYT icon
7
Veracyte
VCYT
$2.88B
$22.6M 5.5%
762,225
+271,678
SNDX icon
8
Syndax Pharmaceuticals
SNDX
$1.34B
$21.3M 5.18%
+1,733,701
LLY icon
9
Eli Lilly
LLY
$725B
$19.6M 4.76%
+23,682
ISRG icon
10
Intuitive Surgical
ISRG
$164B
$18.1M 4.4%
36,499
-411
LIVN icon
11
LivaNova
LIVN
$2.95B
$15M 3.65%
381,648
-130,799
DNTH icon
12
Dianthus Therapeutics
DNTH
$1.43B
$13.8M 3.37%
763,471
INSP icon
13
Inspire Medical Systems
INSP
$2.39B
$13.7M 3.33%
+85,877
GPCR icon
14
Structure Therapeutics
GPCR
$1.61B
$12.2M 2.97%
704,864
+135,469
SLNO icon
15
Soleno Therapeutics
SLNO
$3.48B
$11.5M 2.8%
+160,962
QURE icon
16
uniQure
QURE
$3.94B
$8.8M 2.14%
830,325
-71,648
REGN icon
17
Regeneron Pharmaceuticals
REGN
$61.1B
$7.78M 1.89%
+12,261
SEPN
18
Septerna Inc
SEPN
$1B
$5.93M 1.44%
1,024,245
TARA icon
19
Protara Therapeutics
TARA
$215M
$4.64M 1.13%
1,088,691
ADPT icon
20
Adaptive Biotechnologies
ADPT
$2.72B
$4.54M 1.11%
+611,639
MLTX icon
21
MoonLake Immunotherapeutics
MLTX
$594M
$4.48M 1.09%
+114,616
KROS icon
22
Keros Therapeutics
KROS
$462M
$3.97M 0.97%
389,384
-17,908
VIR icon
23
Vir Biotechnology
VIR
$871M
$3.96M 0.96%
+611,608
REPL icon
24
Replimune Group
REPL
$699M
$3.47M 0.84%
+355,640
ZBIO
25
Zenas BioPharma
ZBIO
$1.23B
$2.33M 0.57%
295,148
+107,964
1
2